Statistics from Altmetric.com
General cardiology, molecular cardiology, interventional cardiology, electrophysiology
β-blockers lower mortality after non-cardiac surgery
The use of preoperative β-blockade to minimise the cardiovascular risks of noncardiac surgery has remained controversial for some time, and recent studies have suggested that preoperative β-blockade may be now decreasing as a result. The purpose of this study was to determine whether early preoperative exposure to β-blockers could influence 30-day postoperative outcomes in patients undergoing noncardiac surgery.
This was a retrospective analysis examining 136 745 patients (1:1 matched on propensity scores) who were given β-blockers on the day of or following major non cardiac surgery. 104 VA hospitals were involved. The main outcome measure was 30-day mortality and cardiac morbidity (cardiac arrest or Q-wave myocardial infarction).
55 138 (40.3%) of patients were exposed to β-blockers, with those undergoing vascular surgery most likely to receive β-blockade (66.7% of all patients undergoing vascular surgery). 1.1% of patients died and cardiac morbidity occurred among 0.9% of patients. After the propensity matching, β-blocker use was associated with lower mortality (relative risk 0.73, p<0.001). When stratified by cumulative numbers of Revised Cardiac Risk Index factors, β-blocker exposure was associated with significantly lower mortality in patients with 2, 3, and 4 risk factors, however this association was limited to patients undergoing nonvascular surgery. A lower rate of cardiac arrest and nonfatal Q-wave infarction was seen in patients given β-blockers (p<0.001), but this again was limited to non-vascular surgery only.
Following propensity matching, preoperative β-blockade was associated with lower rates of 30-day mortality in patients with 2 or more Revised Cardiac Risk Index Factors undergoing non-cardiac, non-vascular surgery.
▸ London MJ, Hur K, Schwartz GG, et al. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA …
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.